Department of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden.
Laboratory of Molecular Biotechnology, Institute of Technology, University of Tartu, Tartu, Estonia.
Methods Mol Biol. 2021;2282:329-352. doi: 10.1007/978-1-0716-1298-9_18.
Cell-Penetrating Peptides (CPP) are valuable tools capable of crossing the plasma membrane to deliver therapeutic cargo inside cells. Small interfering RNAs (siRNA) are double-stranded RNA molecules capable of silencing the expression of a specific protein triggering the RNA interference (RNAi) pathway, but they are unable to cross the plasma membrane and have a short half-life in the bloodstream. In this overview, we assessed the many different approaches used and developed in the last two decades to deliver siRNA through the plasma membrane through different CPPs sorted according to three different loading strategies: covalent conjugation, complex formation, and CPP-decorated (functionalized) nanocomplexes. Each of these strategies has pros and cons, but it appears the latter two are the most commonly reported and emerging as the most promising strategies due to their simplicity of synthesis, use, and versatility. Recent progress with siRNA delivered by CPPs seems to focus on targeted delivery to reduce side effects and amount of drugs used, and it appears to be among the most promising use for CPPs in future clinical applications.
细胞穿透肽(CPP)是一种能够穿过细胞膜将治疗性货物递送到细胞内的有价值的工具。小干扰 RNA(siRNA)是双链 RNA 分子,能够沉默特定蛋白质的表达,触发 RNA 干扰(RNAi)途径,但它们无法穿过细胞膜,并且在血液中的半衰期很短。在这篇综述中,我们评估了过去二十年中通过不同的 CPP 穿过质膜递送 siRNA 的多种不同方法,这些 CPP 根据三种不同的加载策略进行分类:共价偶联、复合物形成和 CPP 修饰(功能化)纳米复合物。这些策略各有优缺点,但后两种策略似乎是最常报道和最有前途的策略,因为它们的合成、使用和多功能性简单。最近使用 CPP 递送 siRNA 的进展似乎侧重于靶向递送来减少副作用和药物使用量,并且似乎是 CPP 在未来临床应用中最有前途的用途之一。